Back to 
Susquehanna International Group, LLP
Susquehanna International Group, LLP
JSPR
Showing 0 of 3 quarters
Position history for Susquehanna International Group, LLP's holdings in Jasper Therapeutics, Inc.
No. Susquehanna International Group exited its JSPR (Jasper Therapeutics) position in Q2 2023. Its Q1 2023 13F listed 13,822 shares worth $25,018. Susquehanna International Group first reported JSPR in Q4 2022 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.